EverHint – Momentum Swing — Aggressive Momentum for Apr 14, 2026 – 2 Signals – Communication Services Leads (1)
What This Signal Is (Quick)
Aggressive Momentum is a momentum swing trading strategy focused on Triple threat: high momentum + high volume + high volatility.
Signal Type: Breakout (momentum continuation)
What Makes This Signal:
- Stock showing strong momentum near or at highs
- Increased volume confirms institutional interest
- Breaking out or consolidating near resistance
- Triple threat: high momentum + high volume + high volatility
Ideal For: Aggressive traders seeking maximum momentum with high risk/reward
Key Criteria:
-
Strong RSI momentum (configurable thresholds)
-
Volume surge above average
-
Price momentum confirmation
-
Minimum ADV: $25M+ (varies by variant)
-
Earnings buffer: 7 days pre/post earnings
-
Variant-specific filters applied
Holding Period: 1-4 weeks
Risk Level: Medium-High
How We Ranked Today
Ranked by composite momentum score (higher = stronger momentum)
📊 Momentum Swing — Aggressive Momentum Signals (2 Total)
Ranked by score:
| Rank | Ticker | Company | Sector | Last ($) | Score | Vol Thrust | @52w | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GSAT | Globalstar, Inc. | Communication Services | 79.91 | 0.300 | 6.69x | 0.0% | — | 22 | $1.05 | 10.3 |
| 2 | TVTX | Travere Therapeutics, ... | Healthcare | 42.13 | 0.000 | 6.83x | 0.0% | $-4.7M | 15 | $5.07 | 3.9 |
Field Notes
Sector concentration: Communication Services (1), Healthcare (1)
Insider selling: TVTX (Travere Therapeutics, Inc., $-4.7M)
Data coverage: 50.0% insider, 0.0% congressional, 100.0% earnings, 100.0% analyst, 50.0% news
Peer Analysis
Understanding how these stocks relate to their industry peers:
TVTX (Travere Therapeutics, Inc.): Leads 10 peers: CGON ($67.28, -0.6%), TARS ($73.81, +1.6%), CELC ($120.85, +0.4%), XENE ($59.35, +1.3%), CNTA ($39.59, +0.1%) | Peer of: ARQT ($25.09, +4.0%), CELC ($120.85, +0.4%), CGON ($67.28, -0.6%) and 9 more
GSAT (Globalstar, Inc.): Leads 6 peers: TKC ($6.42, +0.2%), TDS ($45.49, +0.5%), PHI ($20.65, +0.9%), LUMN ($7.80, +0.1%), MSGS ($339.74, +2.6%) | Peer of: MSGS ($339.74, +2.6%), NXST ($194.11, +5.3%), TKC ($6.42, +0.2%)
Recent Headlines
TVTX (Travere Therapeutics, Inc.)
- FDA Approval For Travere's Drug Expands Reach To Broader Rare Kidney Disease Patients (source)
- Travere Therapeutics Stock Skyrockets On FDA Approval (source)
- Travere Therapeutics, Inc. (TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS Transcript (source)
- US FDA expands approval for Travere Therapeutics' drug for rare kidney disease (source)
- Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS (source)
- Roy Baynes Sells 10,000 Shares of Travere Therapeutics (NASDAQ:TVTX) Stock (source)
- Aberdeen Group plc Trims Holdings in Travere Therapeutics, Inc. $TVTX (source)
Market Context
Broad market indices advanced today, with the Nasdaq leading gains at +1.94%, followed by the S&P 500 at +1.17% and the Dow Jones at +0.66%. This upward trend signals strong risk appetite among investors, favoring aggressive momentum swing strategies that thrive on continued buying pressure. The environment supports capturing intraday swings in the direction of prevailing momentum, particularly as major indices confirm a bullish bias without excessive divergence.
The VIX declined sharply by -3.97% to 18.36, reflecting reduced volatility and a calmer trading atmosphere. While lower volatility can dampen extreme intraday swings—potentially requiring tighter stops for aggressive momentum plays—it still provides ample room for directional moves in a risk-on setting. Momentum strategies benefit here, as moderated fear levels encourage sustained trends rather than erratic reversals.
Sector rotation appears tilted toward growth-oriented areas, aligning with the top-performing Communication Services sector amid Nasdaq's outperformance. This setup enhances the reliability of the two momentum signals, as capital flows into leading sectors amplify swing potential, though traders should monitor for any broadening participation to sustain the aggressive approach.
Sharing Call-to-Action
📊 A simple like, share, or subscribe helps this channel reach more traders who follow data, not noise.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/